GlaxoSmithKline Raises £886 Million from Haleon Plc Share Sale
British pharmaceutical giant GlaxoSmithKline Plc (GSK) has successfully garnered £886 million ($1.1 billion) from its latest share sale in Haleon Plc, the consumer-health entity it
